On March 31, 2026, OrthoPediatrics Corp. amended its Credit Agreement to establish a $20 million delayed draw term loan facility, improving its financial flexibility. The company can access this financing until June 30, 2027, with interest set at SOFR plus 6.50%, among other terms.